Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study. (Q34574044)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q40287783)
(Q40288247)
(Q40287713)
(Q40289010)
(Q40290699)
(Q87734443)
(P304) 1498-1505
(P433) 11
(P478) 91
(P577) Tuesday, October 17, 2006
(P921) (Q181600)
(Q422252)
(Q65592366)
(Q467635)
(P1433) (Q5638209)
(P1476) "Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study" (language: en)
(P2093) Jean-Luc Harousseau
Michel Attal
Jacques Troncy
Anne-Marie Stoppa
Lofti Benboubker
Marc Renaud
Xavier Leleu
Brigitte Pegourie
Cyrille Hulin
Jean-Gabriel Fuzibet
Hervé Avet-Loiseau
other details
description scientific article

External Links